Aronora
Phase 3Aronora is a clinical stage biotech reimagining the future of cardio-hematology with a pipeline of novel therapies along the continuum of thrombotic disease
Founded
2008
Focus
AntibodiesBiologics
About
Aronora is a clinical stage biotech reimagining the future of cardio-hematology with a pipeline of novel therapies along the continuum of thrombotic disease
Funding History
2Total raised: $12.5M
Series A$10MUndisclosedJun 15, 2021
Grant$2.5MNational Institutes of HealthMar 15, 2020
Company Info
TypePrivate
Founded2008
LocationPortland, United States
StagePhase 3
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile